Last 12 months
Inside the activity.
0 purchase rows · 169 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 23 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 44 |
| Feb 2026 | 0 | 22 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 19 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2023 Filed Jan 12, 2023 21:14 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 779 | $17.96 | $13,990.84 |
DisclosureSEC source: 0001628280-23-000963 · wf-form4_167355804099417.xml · nonDerivative · entry 1 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,272 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 779 shares sold at prices ranging from $17.93 to $17.98 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:11 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 2,435 | $17.95 | $43,708.25 |
DisclosureSEC source: 0001628280-23-000961 · wf-form4_167355789878115.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,159 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 2,435 shares sold at prices ranging from $17.93 to $17.96 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:13 UTC |
Smith Michael AlexanderGeneral Counsel, Senior VP
|
SaleCommon Stock | 1,836 | $17.93 | $32,919.48 |
DisclosureSEC source: 0001628280-23-000962 · wf-form4_167355796596777.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,332 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 1,836 shares sold at prices ranging from $17.92 to $17.96 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:10 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 6,994 | $18.00 | $125,892.00 |
DisclosureSEC source: 0001628280-23-000960 · wf-form4_167355782601813.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,067 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is a weighted average sales price representing 6,994 shares sold at prices ranging from $17.97 to $18.02 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:09 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 3,439 | $18.06 | $62,108.34 |
DisclosureSEC source: 0001628280-23-000959 · wf-form4_167355774353218.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,763 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 3,439 shares sold at prices ranging from $18.04 to $18.08 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:08 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 2,857 | $18.12 | $51,768.84 |
DisclosureSEC source: 0001628280-23-000958 · wf-form4_167355767379058.xml · nonDerivative · entry 1 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,031 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 2,857 shares sold at prices ranging from $18.03 to $18.19 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:06 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 3,194 | $17.99 | $57,460.06 |
DisclosureSEC source: 0001628280-23-000957 · wf-form4_167355760242570.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,487 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 3,194 shares sold at prices ranging from $17.98 to $18.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:30 UTC |
Wise John DraytonChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 34,860 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0001930805-23-000001 · wf-form4_167304064330467.xml · derivative · entry 3 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,860 Underlying: Common Stock · 34,860 shares Expires 2033-01-05 F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:30 UTC |
Wise John DraytonChief Commercial Officer
|
GrantCommon Stock | 7,598 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001930805-23-000001 · wf-form4_167304064330467.xml · nonDerivative · entry 2 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,051 F2 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant. F3 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:30 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 1,160 | $19.74 | $22,898.40 |
DisclosureSEC source: 0001930805-23-000001 · wf-form4_167304064330467.xml · nonDerivative · entry 1 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,453 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:29 UTC |
Smith Michael AlexanderGeneral Counsel, Senior VP
|
GrantStock Option (right to buy) · Derivative | 29,050 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0001870278-23-000001 · wf-form4_167304054671097.xml · derivative · entry 3 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,050 Underlying: Common Stock · 29,050 shares Expires 2033-01-05 F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:29 UTC |
Smith Michael AlexanderGeneral Counsel, Senior VP
|
GrantCommon Stock | 6,332 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001870278-23-000001 · wf-form4_167304054671097.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,168 F3 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant. F4 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:29 UTC |
Smith Michael AlexanderGeneral Counsel, Senior VP
|
SaleCommon Stock | 720 | $19.72 | $14,198.40 |
DisclosureSEC source: 0001870278-23-000001 · wf-form4_167304054671097.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,836 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · balance_after: Includes 101 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:27 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantStock Option (right to buy) · Derivative | 29,050 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0001401017-23-000001 · wf-form4_167304043493381.xml · derivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,050 Underlying: Common Stock · 29,050 shares Expires 2033-01-05 F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:27 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
GrantCommon Stock | 6,332 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001401017-23-000001 · wf-form4_167304043493381.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,594 F3 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant. F4 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:27 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 1,448 | $19.73 | $28,569.04 |
DisclosureSEC source: 0001401017-23-000001 · wf-form4_167304043493381.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,262 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · balance_after: Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:24 UTC |
Lewis WilliamDirector · Chair and CEO
|
GrantStock Option (right to buy) · Derivative | 102,540 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0001402051-23-000001 · wf-form4_167304024350073.xml · derivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,540 Underlying: Common Stock · 102,540 shares Expires 2033-01-05 F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:24 UTC |
Lewis WilliamDirector · Chair and CEO
|
GrantCommon Stock | 22,353 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001402051-23-000001 · wf-form4_167304024350073.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,061 F3 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant. F4 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:24 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 7,008 | $19.80 | $138,758.40 |
DisclosureSEC source: 0001402051-23-000001 · wf-form4_167304024350073.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,708 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is a weighted average sales price representing 7,008 shares sold at prices ranging from $19.78 to $19.805 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:22 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 34,860 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0001796960-23-000001 · wf-form4_167304014062436.xml · derivative · entry 4 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,860 Underlying: Common Stock · 34,860 shares Expires 2033-01-05 F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of the grant. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:22 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantCommon Stock | 3,546 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001796960-23-000001 · wf-form4_167304014062436.xml · nonDerivative · entry 3 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,202 F4 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: one third on each anniversary of the date of grant through the third anniversary date of the date of the grant. F3 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:22 UTC |
Flammer Martina M.D.Chief Medical Officer
|
GrantCommon Stock | 7,598 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001796960-23-000001 · wf-form4_167304014062436.xml · nonDerivative · entry 2 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,656 F2 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant. F3 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:22 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 1,374 | $19.73 | $27,109.02 |
DisclosureSEC source: 0001796960-23-000001 · wf-form4_167304014062436.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,058 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:17 UTC |
Bonstein SaraChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 37,760 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0001628280-23-000632 · wf-form4_167303980436597.xml · derivative · entry 3 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,760 Underlying: Common Stock · 37,760 shares Expires 2033-01-05 F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of the grant. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:17 UTC |
Bonstein SaraChief Financial Officer
|
GrantCommon Stock | 5,065 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-000632 · wf-form4_167303980436597.xml · nonDerivative · entry 2 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,888 F4 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: one third on each anniversary of the date of grant through the third anniversary date of the date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:17 UTC |
Bonstein SaraChief Financial Officer
|
GrantCommon Stock | 8,232 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-000632 · wf-form4_167303980436597.xml · nonDerivative · entry 1 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,823 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration. F3 · balance_after: Includes 908 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:08 UTC |
Adsett RogerChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 34,860 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0001685904-23-000001 · wf-form4_167303931068897.xml · derivative · entry 3 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,860 Underlying: Common Stock · 34,860 shares Expires 2033-01-05 F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of the grant. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:08 UTC |
Adsett RogerChief Operating Officer
|
GrantCommon Stock | 7,598 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001685904-23-000001 · wf-form4_167303931068897.xml · nonDerivative · entry 2 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,681 F2 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant. F3 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:08 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 3,044 | $19.75 | $60,119.00 |
DisclosureSEC source: 0001685904-23-000001 · wf-form4_167303931068897.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,083 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| November 22, 2022 Filed Nov 22, 2022 22:05 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 7,154 | $18.84 | $134,781.36 |
DisclosureSEC source: 0001930805-22-000002 · wf-form4_166915469420395.xml · nonDerivative · entry 1 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,613 F1 · shares: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. Read SEC document |
| November 22, 2022 Filed Nov 22, 2022 22:03 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 11,855 | $18.80 | $222,874.00 |
DisclosureSEC source: 0001685904-22-000001 · wf-form4_166915458164192.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,127 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. F2 · price: This is the weighted average sales price representing the shares sold at prices ranging from $18.78 to $18.86 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 20:23 UTC |
SHAROKY MELVIN MDDirector
|
PurchaseCommon Stock | 10,000 | $17.70 | $177,000.00 |
DisclosureSEC source: 0001182633-22-000002 · wf-form4_166742056037010.xml · nonDerivative · entry 2 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Baby Gator LLC Disclosed balance after: 15,900 F2 · price: This is the weighted average purchase price representing the shares purchased at prices ranging from $17.68 to $17.70 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request. F3 · ownership.nature: The Reporting Person is a managing member of Baby Gator LLC. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 20:20 UTC |
LEE LEODirector
|
PurchaseCommon Stock | 45,000 | $17.69 | $796,050.00 |
DisclosureSEC source: 0001740789-22-000002 · wf-form4_166742043602523.xml · nonDerivative · entry 1 LEE LEO · CIK 0001740789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,265 Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 20:23 UTC |
SHAROKY MELVIN MDDirector
|
PurchaseCommon Stock | 20,000 | $17.53 | $350,600.00 |
DisclosureSEC source: 0001182633-22-000002 · wf-form4_166742056037010.xml · nonDerivative · entry 1 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,021 F1 · price: This is the weighted average purchase price representing the shares purchased at prices ranging from $17.32 to $17.63 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request. Read SEC document |
| October 31, 2022 Filed Jan 12, 2023 21:16 UTC |
SHAROKY MELVIN MDDirector
|
GiftCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000964 · wf-form5_167355815576336.xml · nonDerivative · entry 1 SHAROKY MELVIN MD · CIK 0001182633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,021 Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:19 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 258 | $27.79 | $7,169.82 |
DisclosureSEC source: 0001930805-22-000001 · wf-form4_166033556150179.xml · nonDerivative · entry 1 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,767 F1 · shares: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. F2 · balance_after: Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 186,170 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · derivative · entry 11 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Disclosed balance after: 0 Underlying: Common Stock · 186,170 shares Expires 2022-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 30,630 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · derivative · entry 10 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Disclosed balance after: 0 Underlying: Common Stock · 30,630 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 24,977 | $28.43 | $710,096.11 |
DisclosureSEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 8 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Indirect Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: This is the weighted average sales price representing 24,977 shares sold at prices ranging from $28.26 to $28.72 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 24,977 | $4.55 | $113,645.35 |
DisclosureSEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 7 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Indirect Disclosed balance after: 24,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 161,193 | $27.75 | $4,473,105.75 |
DisclosureSEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 6 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Indirect Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 161,193 shares sold at prices ranging from $27.26 to $28.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 161,193 | $4.55 | $733,428.15 |
DisclosureSEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Indirect Disclosed balance after: 161,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 6,200 | $28.45 | $176,390.00 |
DisclosureSEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Indirect Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 6,200 shares sold at prices ranging from $28.26 to $28.73 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 6,200 | $3.40 | $21,080.00 |
DisclosureSEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Indirect Disclosed balance after: 6,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 24,430 | $27.67 | $675,978.10 |
DisclosureSEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Indirect Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 24,430 shares sold at prices ranging from $27.26 to $28.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:18 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 24,430 | $3.40 | $83,062.00 |
DisclosureSEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Indirect Disclosed balance after: 24,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Read SEC document |
| July 12, 2022 Filed Jul 12, 2022 20:06 UTC |
Smith Michael AlexanderGeneral Counsel, Senior VP
|
SaleCommon Stock | 941 | $23.40 | $22,019.40 |
DisclosureSEC source: 0001870278-22-000001 · wf-form4_165765636118954.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,455 F1 · shares: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. F2 · balance_after: Includes 813 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 20:04 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 96,614 | $0.00 Strike: $16.16 | $0.00 |
DisclosureSEC source: 0001402051-22-000002 · wf-form4_165731066077799.xml · derivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 96,614 shares Expires 2026-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 20:04 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 96,614 | $23.00 | $2,222,122.00 |
DisclosureSEC source: 0001402051-22-000002 · wf-form4_165731066077799.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,716 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 96,614 shares sold at prices ranging from $23.00 to $23.03 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 20:04 UTC |
Lewis WilliamDirector · Chair and CEO
|
Exercise / conversionCommon Stock | 96,614 | $16.16 | $1,561,282.24 |
DisclosureSEC source: 0001402051-22-000002 · wf-form4_165731066077799.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,330 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.